Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 21.90
+0.90 (4.29%)
At close: Apr 28, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 126.31 million as of April 28, 2026. Its market cap has increased by 17.01% in one year.
Market Cap
126.31M
Enterprise Value
273.82M
Revenue
839.38K
Ranking
n/a
PE Ratio
4.82
Stock Price
21.90
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 126.31M, a decrease of -47.47%. That is a compound annual growth rate of -14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 121.12M | -14.98% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 125.33M |
| BioVersys AG | 172.52M |
| Santhera Pharmaceuticals Holding AG | 258.20M |
| Newron Pharmaceuticals | 318.74M |
| MindMaze Therapeutics Holding | 41.97M |
| Basilea Pharmaceutica AG | 653.91M |
| Idorsia | 991.94M |
| EvoNext Holdings | 6.88M |